This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rahmouni, K. Articles by De Jong, W. Search for Related Content PubMed PubMed Citation Articles by Rahmouni, K. Articles by De Jong, W. Related Collections Hypertension - basic studies Receptor pharmacology

(Hypertension. 1999;33:1201-1206.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Brain Mineralocorticoid Receptor Control of Blood Pressure and Kidney Function in Normotensive Rats

Kamal Rahmouni; Mariette Barthelmebs; Michèle Grima; Jean-Louis Imbs; Wybren De Jong

From the Institut de Pharmacologie (K.R., M.B., M.G., J.-L.I., W.D.J.) and Laboratoire de Pharmacologie-Physiologie Rénovasculaire, Faculté de Médecine, Université Louis Pasteur (K.R., M.B., M.G., J.-L.I.), and Service d'Hypertension artérielle, Maladies vasculaires et Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg (J.-L.I.), Strasbourg, France.

Correspondence to Prof Wybren De Jong, Institut de Pharmacologie, 11 rue Humann, 67085 Strasbourg Cedex, France.

Abstract—Brain mineralocorticoid receptors appear to contribute to mineralocorticoid hypertension and may be involved in blood pressure control in normotensive rats. We examined the effect of blockade of central mineralocorticoid receptors with the use of a selective antagonist (RU28318) on cardiovascular and renal function in conscious normotensive rats. The contribution of renal innervation was evaluated in rats with bilaterally denervated kidneys. Young adult, male Wistar rats were trained for systolic blood pressure measurement by a tail sphygmographic method and accustomed to metabolic cages for collection of urine. One week before experimentation, an intracerebroventricular cannula was implanted. Systolic blood pressure was diminished 30 minutes after an intracerebroventricular dose of 10 ng of RU28318. The effect was maximal at 8 hours and was still present after 24 hours. Blood pressure returned to the basal level by 48 hours. During the period 0 to 8 hours after intracerebroventricular injection, rats treated with the antagonist showed an increase in diuresis and urinary electrolyte excretion. No significant effect on plasma renin activity, measured 8 and 30 hours after administration of RU28318, was observed. In denervated rats, the decrease in systolic blood pressure after administration of RU28318 was reduced. The difference was statistically significant compared with controls at 2 hours but not at 8 hours, and blood pressure returned to the basal value by 24 hours. The increases in diuresis and urinary electrolyte excretion induced by RU28318 were abolished in denervated rats. These results show that brain mineralocorticoid receptors are involved in blood pressure regulation and kidney function homeostasis in conscious normotensive rats. The renal nerves appear to participate in the brain mineralocorticoid receptor control of blood pressure.

Key Words: receptors, mineralocorticoid • blood pressure • RU28318 • denervation • electrolytes • diuresis

This article has been cited by other articles:

				Z. Sun, M. Bello-Roufai, and X. Wang RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1880 - H1887. [Abstract] [Full Text] [PDF]

				R. H. DeRijk, S. Wust, O. C. Meijer, M.-C. Zennaro, I. S. Federenko, D. H. Hellhammer, G. Giacchetti, E. Vreugdenhil, F. G. Zitman, and E. R. de Kloet A Common Polymorphism in the Mineralocorticoid Receptor Modulates Stress Responsiveness J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5083 - 5089. [Abstract] [Full Text] [PDF]

				J. Francis, S.-G. Wei, R. M. Weiss, and R. B. Felder Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2138 - H2146. [Abstract] [Full Text] [PDF]

				Z. Wu, C. Maric, D. M. Roesch, W. Zheng, J. G. Verbalis, and K. Sandberg Estrogen Regulates Adrenal Angiotensin AT1 Receptors by Modulating AT1 Receptor Translation Endocrinology, July 1, 2003; 144(7): 3251 - 3261. [Abstract] [Full Text] [PDF]

				J. Francis, R. M. Weiss, A. K. Johnson, and R. B. Felder Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R328 - R335. [Abstract] [Full Text] [PDF]

				C. E. Gomez-Sanchez and E. P. Gomez-Sanchez Cardiac Steroidogenesis--New Sites of Synthesis, or Much Ado About Nothing? J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5118 - 5120. [Full Text] [PDF]

				J. Francis, R. M. Weiss, S.-G. Wei, A. K. Johnson, T. G. Beltz, K. Zimmerman, and R. B. Felder Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2241 - H2251. [Abstract] [Full Text] [PDF]

				H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. Barthelmebs, M. Grima, J.-L. Imbs, and W. De Jong Involvement of Brain Mineralocorticoid Receptor in Salt-Enhanced Hypertension in Spontaneously Hypertensive Rats Hypertension, October 1, 2001; 38(4): 902 - 906. [Abstract] [Full Text] [PDF]

				D. M. Roesch, Y. Tian, W. Zheng, M. Shi, J. G. Verbalis, and K. Sandberg Estradiol Attenuates Angiotensin-Induced Aldosterone Secretion in Ovariectomized Rats Endocrinology, December 1, 2000; 141(12): 4629 - 4636. [Abstract] [Full Text] [PDF]